呼吸作動式吸入器のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Breath Actuated Inhalers Market Insights, Forecast to 2028

• レポートコード：QY2203B08991 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の呼吸作動式吸入器の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に呼吸作動式吸入器の世界市場のxxx％を占める「単回投与」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「喘息」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の呼吸作動式吸入器の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの呼吸作動式吸入器市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの呼吸作動式吸入器市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 呼吸作動式吸入器のグローバル主要メーカーには、GlaxoSmithKline、AstraZeneca、Boehringer Ingelheim、Chiesi、Cipla、3M、Hovione、Mannkind、Meda、Novartis、Schering/Merckなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 呼吸作動式吸入器市場は、種類と用途によって区分されます。世界の呼吸作動式吸入器市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 単回投与、複数回投与 【用途別セグメント】 喘息、COPD、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 呼吸作動式吸入器製品概要 - 種類別市場（単回投与、複数回投与） - 用途別市場（喘息、COPD、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の呼吸作動式吸入器販売量予測2017-2028 - 世界の呼吸作動式吸入器売上予測2017-2028 - 呼吸作動式吸入器の地域別販売量 - 呼吸作動式吸入器の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別呼吸作動式吸入器販売量 - 主要メーカー別呼吸作動式吸入器売上 - 主要メーカー別呼吸作動式吸入器価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（単回投与、複数回投与） - 呼吸作動式吸入器の種類別販売量 - 呼吸作動式吸入器の種類別売上 - 呼吸作動式吸入器の種類別価格 ・用途別市場規模（喘息、COPD、その他） - 呼吸作動式吸入器の用途別販売量 - 呼吸作動式吸入器の用途別売上 - 呼吸作動式吸入器の用途別価格 ・北米市場 - 北米の呼吸作動式吸入器市場規模（種類別、用途別） - 主要国別の呼吸作動式吸入器市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの呼吸作動式吸入器市場規模（種類別、用途別） - 主要国別の呼吸作動式吸入器市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の呼吸作動式吸入器市場規模（種類別、用途別） - 主要国別の呼吸作動式吸入器市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の呼吸作動式吸入器市場規模（種類別、用途別） - 主要国別の呼吸作動式吸入器市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの呼吸作動式吸入器市場規模（種類別、用途別） - 主要国別の呼吸作動式吸入器市場規模（トルコ、サウジアラビア） ・企業情報 GlaxoSmithKline、AstraZeneca、Boehringer Ingelheim、Chiesi、Cipla、3M、Hovione、Mannkind、Meda、Novartis、Schering/Merck ・産業チェーン及び販売チャネル分析 - 呼吸作動式吸入器の産業チェーン分析 - 呼吸作動式吸入器の原材料 - 呼吸作動式吸入器の生産プロセス - 呼吸作動式吸入器の販売及びマーケティング - 呼吸作動式吸入器の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 呼吸作動式吸入器の産業動向 - 呼吸作動式吸入器のマーケットドライバー - 呼吸作動式吸入器の課題 - 呼吸作動式吸入器の阻害要因 ・主な調査結果

A breath actuated inhaler is a type of inhaler that delivers asthma medication to lungs. With this type of breath actuated inhaler, the medication is driven into lungs during inhalation instead of via a propellant.
Market Analysis and Insights: Global Breath Actuated Inhalers Market
Due to the COVID-19 pandemic, the global Breath Actuated Inhalers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Single Dose accounting for % of the Breath Actuated Inhalers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Asthma segment is altered to an % CAGR throughout this forecast period.
China Breath Actuated Inhalers market size is valued at US$ million in 2021, while the US and Europe Breath Actuated Inhalers are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Breath Actuated Inhalers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Breath Actuated Inhalers include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Meda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Breath Actuated Inhalers Scope and Segment
Breath Actuated Inhalers market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Breath Actuated Inhalers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Single Dose
Multi-Dose
Segment by Application
Asthma
COPD
Others
By Company
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Meda
Novartis
Schering/Merck
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Breath Actuated Inhalers Product Introduction
1.2 Market by Type
1.2.1 Global Breath Actuated Inhalers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Single Dose
1.2.3 Multi-Dose
1.3 Market by Application
1.3.1 Global Breath Actuated Inhalers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Breath Actuated Inhalers Sales Estimates and Forecasts 2017-2028
2.2 Global Breath Actuated Inhalers Revenue Estimates and Forecasts 2017-2028
2.3 Global Breath Actuated Inhalers Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Breath Actuated Inhalers Sales by Region
2.4.1 Global Breath Actuated Inhalers Sales by Region (2017-2022)
2.4.2 Global Sales Breath Actuated Inhalers by Region (2023-2028)
2.5 Global Breath Actuated Inhalers Revenue by Region
2.5.1 Global Breath Actuated Inhalers Revenue by Region (2017-2022)
2.5.2 Global Breath Actuated Inhalers Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Breath Actuated Inhalers Sales by Manufacturers
3.1.1 Global Top Breath Actuated Inhalers Manufacturers by Sales (2017-2022)
3.1.2 Global Breath Actuated Inhalers Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Breath Actuated Inhalers in 2021
3.2 Global Breath Actuated Inhalers Revenue by Manufacturers
3.2.1 Global Breath Actuated Inhalers Revenue by Manufacturers (2017-2022)
3.2.2 Global Breath Actuated Inhalers Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Breath Actuated Inhalers Revenue in 2021
3.3 Global Breath Actuated Inhalers Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Breath Actuated Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Breath Actuated Inhalers Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Breath Actuated Inhalers Sales by Type
4.1.1 Global Breath Actuated Inhalers Historical Sales by Type (2017-2022)
4.1.2 Global Breath Actuated Inhalers Forecasted Sales by Type (2023-2028)
4.1.3 Global Breath Actuated Inhalers Sales Market Share by Type (2017-2028)
4.2 Global Breath Actuated Inhalers Revenue by Type
4.2.1 Global Breath Actuated Inhalers Historical Revenue by Type (2017-2022)
4.2.2 Global Breath Actuated Inhalers Forecasted Revenue by Type (2023-2028)
4.2.3 Global Breath Actuated Inhalers Revenue Market Share by Type (2017-2028)
4.3 Global Breath Actuated Inhalers Price by Type
4.3.1 Global Breath Actuated Inhalers Price by Type (2017-2022)
4.3.2 Global Breath Actuated Inhalers Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Breath Actuated Inhalers Sales by Application
5.1.1 Global Breath Actuated Inhalers Historical Sales by Application (2017-2022)
5.1.2 Global Breath Actuated Inhalers Forecasted Sales by Application (2023-2028)
5.1.3 Global Breath Actuated Inhalers Sales Market Share by Application (2017-2028)
5.2 Global Breath Actuated Inhalers Revenue by Application
5.2.1 Global Breath Actuated Inhalers Historical Revenue by Application (2017-2022)
5.2.2 Global Breath Actuated Inhalers Forecasted Revenue by Application (2023-2028)
5.2.3 Global Breath Actuated Inhalers Revenue Market Share by Application (2017-2028)
5.3 Global Breath Actuated Inhalers Price by Application
5.3.1 Global Breath Actuated Inhalers Price by Application (2017-2022)
5.3.2 Global Breath Actuated Inhalers Price Forecast by Application (2023-2028)
6 North America
6.1 North America Breath Actuated Inhalers Market Size by Type
6.1.1 North America Breath Actuated Inhalers Sales by Type (2017-2028)
6.1.2 North America Breath Actuated Inhalers Revenue by Type (2017-2028)
6.2 North America Breath Actuated Inhalers Market Size by Application
6.2.1 North America Breath Actuated Inhalers Sales by Application (2017-2028)
6.2.2 North America Breath Actuated Inhalers Revenue by Application (2017-2028)
6.3 North America Breath Actuated Inhalers Market Size by Country
6.3.1 North America Breath Actuated Inhalers Sales by Country (2017-2028)
6.3.2 North America Breath Actuated Inhalers Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Breath Actuated Inhalers Market Size by Type
7.1.1 Europe Breath Actuated Inhalers Sales by Type (2017-2028)
7.1.2 Europe Breath Actuated Inhalers Revenue by Type (2017-2028)
7.2 Europe Breath Actuated Inhalers Market Size by Application
7.2.1 Europe Breath Actuated Inhalers Sales by Application (2017-2028)
7.2.2 Europe Breath Actuated Inhalers Revenue by Application (2017-2028)
7.3 Europe Breath Actuated Inhalers Market Size by Country
7.3.1 Europe Breath Actuated Inhalers Sales by Country (2017-2028)
7.3.2 Europe Breath Actuated Inhalers Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Breath Actuated Inhalers Market Size by Type
8.1.1 Asia Pacific Breath Actuated Inhalers Sales by Type (2017-2028)
8.1.2 Asia Pacific Breath Actuated Inhalers Revenue by Type (2017-2028)
8.2 Asia Pacific Breath Actuated Inhalers Market Size by Application
8.2.1 Asia Pacific Breath Actuated Inhalers Sales by Application (2017-2028)
8.2.2 Asia Pacific Breath Actuated Inhalers Revenue by Application (2017-2028)
8.3 Asia Pacific Breath Actuated Inhalers Market Size by Region
8.3.1 Asia Pacific Breath Actuated Inhalers Sales by Region (2017-2028)
8.3.2 Asia Pacific Breath Actuated Inhalers Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Breath Actuated Inhalers Market Size by Type
9.1.1 Latin America Breath Actuated Inhalers Sales by Type (2017-2028)
9.1.2 Latin America Breath Actuated Inhalers Revenue by Type (2017-2028)
9.2 Latin America Breath Actuated Inhalers Market Size by Application
9.2.1 Latin America Breath Actuated Inhalers Sales by Application (2017-2028)
9.2.2 Latin America Breath Actuated Inhalers Revenue by Application (2017-2028)
9.3 Latin America Breath Actuated Inhalers Market Size by Country
9.3.1 Latin America Breath Actuated Inhalers Sales by Country (2017-2028)
9.3.2 Latin America Breath Actuated Inhalers Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Breath Actuated Inhalers Market Size by Type
10.1.1 Middle East and Africa Breath Actuated Inhalers Sales by Type (2017-2028)
10.1.2 Middle East and Africa Breath Actuated Inhalers Revenue by Type (2017-2028)
10.2 Middle East and Africa Breath Actuated Inhalers Market Size by Application
10.2.1 Middle East and Africa Breath Actuated Inhalers Sales by Application (2017-2028)
10.2.2 Middle East and Africa Breath Actuated Inhalers Revenue by Application (2017-2028)
10.3 Middle East and Africa Breath Actuated Inhalers Market Size by Country
10.3.1 Middle East and Africa Breath Actuated Inhalers Sales by Country (2017-2028)
10.3.2 Middle East and Africa Breath Actuated Inhalers Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Chiesi
11.4.1 Chiesi Corporation Information
11.4.2 Chiesi Overview
11.4.3 Chiesi Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Chiesi Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chiesi Recent Developments
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Overview
11.5.3 Cipla Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cipla Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cipla Recent Developments
11.6 3M
11.6.1 3M Corporation Information
11.6.2 3M Overview
11.6.3 3M Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 3M Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 3M Recent Developments
11.7 Hovione
11.7.1 Hovione Corporation Information
11.7.2 Hovione Overview
11.7.3 Hovione Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hovione Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hovione Recent Developments
11.8 Mannkind
11.8.1 Mannkind Corporation Information
11.8.2 Mannkind Overview
11.8.3 Mannkind Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mannkind Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mannkind Recent Developments
11.9 Meda
11.9.1 Meda Corporation Information
11.9.2 Meda Overview
11.9.3 Meda Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Meda Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Meda Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Schering/Merck
11.11.1 Schering/Merck Corporation Information
11.11.2 Schering/Merck Overview
11.11.3 Schering/Merck Breath Actuated Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Schering/Merck Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Schering/Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Breath Actuated Inhalers Industry Chain Analysis
12.2 Breath Actuated Inhalers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Breath Actuated Inhalers Production Mode & Process
12.4 Breath Actuated Inhalers Sales and Marketing
12.4.1 Breath Actuated Inhalers Sales Channels
12.4.2 Breath Actuated Inhalers Distributors
12.5 Breath Actuated Inhalers Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Breath Actuated Inhalers Industry Trends
13.2 Breath Actuated Inhalers Market Drivers
13.3 Breath Actuated Inhalers Market Challenges
13.4 Breath Actuated Inhalers Market Restraints
14 Key Findings in The Global Breath Actuated Inhalers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Breath Actuated Inhalers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Single Dose
Table 3. Major Manufacturers of Multi-Dose
Table 4. Global Breath Actuated Inhalers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Breath Actuated Inhalers Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Breath Actuated Inhalers Sales by Region (2017-2022) & (K Units)
Table 7. Global Breath Actuated Inhalers Sales Market Share by Region (2017-2022)
Table 8. Global Breath Actuated Inhalers Sales by Region (2023-2028) & (K Units)
Table 9. Global Breath Actuated Inhalers Sales Market Share by Region (2023-2028)
Table 10. Global Breath Actuated Inhalers Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Breath Actuated Inhalers Revenue Market Share by Region (2017-2022)
Table 12. Global Breath Actuated Inhalers Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Breath Actuated Inhalers Revenue Market Share by Region (2023-2028)
Table 14. Global Breath Actuated Inhalers Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Breath Actuated Inhalers Sales Share by Manufacturers (2017-2022)
Table 16. Global Breath Actuated Inhalers Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Breath Actuated Inhalers Revenue Share by Manufacturers (2017-2022)
Table 18. Breath Actuated Inhalers Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Breath Actuated Inhalers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Breath Actuated Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breath Actuated Inhalers as of 2021)
Table 21. Breath Actuated Inhalers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Breath Actuated Inhalers Product Offered
Table 23. Date of Manufacturers Enter into Breath Actuated Inhalers Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Breath Actuated Inhalers Sales by Type (2017-2022) & (K Units)
Table 26. Global Breath Actuated Inhalers Sales by Type (2023-2028) & (K Units)
Table 27. Global Breath Actuated Inhalers Sales Share by Type (2017-2022)
Table 28. Global Breath Actuated Inhalers Sales Share by Type (2023-2028)
Table 29. Global Breath Actuated Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Breath Actuated Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Breath Actuated Inhalers Revenue Share by Type (2017-2022)
Table 32. Global Breath Actuated Inhalers Revenue Share by Type (2023-2028)
Table 33. Breath Actuated Inhalers Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Breath Actuated Inhalers Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Breath Actuated Inhalers Sales by Application (2017-2022) & (K Units)
Table 36. Global Breath Actuated Inhalers Sales by Application (2023-2028) & (K Units)
Table 37. Global Breath Actuated Inhalers Sales Share by Application (2017-2022)
Table 38. Global Breath Actuated Inhalers Sales Share by Application (2023-2028)
Table 39. Global Breath Actuated Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Breath Actuated Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Breath Actuated Inhalers Revenue Share by Application (2017-2022)
Table 42. Global Breath Actuated Inhalers Revenue Share by Application (2023-2028)
Table 43. Breath Actuated Inhalers Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Breath Actuated Inhalers Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Breath Actuated Inhalers Sales by Type (2017-2022) & (K Units)
Table 46. North America Breath Actuated Inhalers Sales by Type (2023-2028) & (K Units)
Table 47. North America Breath Actuated Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Breath Actuated Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Breath Actuated Inhalers Sales by Application (2017-2022) & (K Units)
Table 50. North America Breath Actuated Inhalers Sales by Application (2023-2028) & (K Units)
Table 51. North America Breath Actuated Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Breath Actuated Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Breath Actuated Inhalers Sales by Country (2017-2022) & (K Units)
Table 54. North America Breath Actuated Inhalers Sales by Country (2023-2028) & (K Units)
Table 55. North America Breath Actuated Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Breath Actuated Inhalers Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Breath Actuated Inhalers Sales by Type (2017-2022) & (K Units)
Table 58. Europe Breath Actuated Inhalers Sales by Type (2023-2028) & (K Units)
Table 59. Europe Breath Actuated Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Breath Actuated Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Breath Actuated Inhalers Sales by Application (2017-2022) & (K Units)
Table 62. Europe Breath Actuated Inhalers Sales by Application (2023-2028) & (K Units)
Table 63. Europe Breath Actuated Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Breath Actuated Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Breath Actuated Inhalers Sales by Country (2017-2022) & (K Units)
Table 66. Europe Breath Actuated Inhalers Sales by Country (2023-2028) & (K Units)
Table 67. Europe Breath Actuated Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Breath Actuated Inhalers Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Breath Actuated Inhalers Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Breath Actuated Inhalers Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Breath Actuated Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Breath Actuated Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Breath Actuated Inhalers Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Breath Actuated Inhalers Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Breath Actuated Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Breath Actuated Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Breath Actuated Inhalers Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Breath Actuated Inhalers Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Breath Actuated Inhalers Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Breath Actuated Inhalers Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Breath Actuated Inhalers Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Breath Actuated Inhalers Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Breath Actuated Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Breath Actuated Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Breath Actuated Inhalers Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Breath Actuated Inhalers Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Breath Actuated Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Breath Actuated Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Breath Actuated Inhalers Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Breath Actuated Inhalers Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Breath Actuated Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Breath Actuated Inhalers Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Breath Actuated Inhalers Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Breath Actuated Inhalers Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Breath Actuated Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Breath Actuated Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Breath Actuated Inhalers Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Breath Actuated Inhalers Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Breath Actuated Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Breath Actuated Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Breath Actuated Inhalers Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Breath Actuated Inhalers Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Breath Actuated Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Breath Actuated Inhalers Revenue by Country (2023-2028) & (US$ Million)
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Major Businesses
Table 107. GlaxoSmithKline Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. GlaxoSmithKline Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. GlaxoSmithKline Recent Developments
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Major Businesses
Table 112. AstraZeneca Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. AstraZeneca Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. AstraZeneca Recent Developments
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Major Businesses
Table 117. Boehringer Ingelheim Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Boehringer Ingelheim Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Chiesi Corporation Information
Table 121. Chiesi Description and Major Businesses
Table 122. Chiesi Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Chiesi Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Chiesi Recent Developments
Table 125. Cipla Corporation Information
Table 126. Cipla Description and Major Businesses
Table 127. Cipla Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Cipla Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Cipla Recent Developments
Table 130. 3M Corporation Information
Table 131. 3M Description and Major Businesses
Table 132. 3M Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. 3M Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. 3M Recent Developments
Table 135. Hovione Corporation Information
Table 136. Hovione Description and Major Businesses
Table 137. Hovione Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Hovione Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Hovione Recent Developments
Table 140. Mannkind Corporation Information
Table 141. Mannkind Description and Major Businesses
Table 142. Mannkind Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Mannkind Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Mannkind Recent Developments
Table 145. Meda Corporation Information
Table 146. Meda Description and Major Businesses
Table 147. Meda Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Meda Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Meda Recent Developments
Table 150. Novartis Corporation Information
Table 151. Novartis Description and Major Businesses
Table 152. Novartis Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Novartis Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Novartis Recent Developments
Table 155. Schering/Merck Corporation Information
Table 156. Schering/Merck Description and Major Businesses
Table 157. Schering/Merck Breath Actuated Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Schering/Merck Breath Actuated Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Schering/Merck Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Breath Actuated Inhalers Distributors List
Table 163. Breath Actuated Inhalers Customers List
Table 164. Breath Actuated Inhalers Market Trends
Table 165. Breath Actuated Inhalers Market Drivers
Table 166. Breath Actuated Inhalers Market Challenges
Table 167. Breath Actuated Inhalers Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Breath Actuated Inhalers Product Picture
Figure 3. Global Breath Actuated Inhalers Market Share by Type in 2021 & 2028
Figure 3. Single Dose Product Picture
Figure 4. Multi-Dose Product Picture
Figure 5. Global Breath Actuated Inhalers Market Share by Application in 2021 & 2028
Figure 6. Asthma
Figure 7. COPD
Figure 8. Others
Figure 9. Breath Actuated Inhalers Report Years Considered
Figure 10. Global Breath Actuated Inhalers Sales 2017-2028 (K Units)
Figure 11. Global Breath Actuated Inhalers Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Breath Actuated Inhalers Revenue 2017-2028 (US$ Million)
Figure 13. Global Breath Actuated Inhalers Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Breath Actuated Inhalers Sales Market Share by Region (2017-2022)
Figure 15. Global Breath Actuated Inhalers Sales Market Share by Region (2023-2028)
Figure 16. North America Breath Actuated Inhalers Sales YoY (2017-2028) & (K Units)
Figure 17. North America Breath Actuated Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Breath Actuated Inhalers Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Breath Actuated Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Breath Actuated Inhalers Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Breath Actuated Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Breath Actuated Inhalers Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Breath Actuated Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Breath Actuated Inhalers Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Breath Actuated Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Breath Actuated Inhalers Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Breath Actuated Inhalers in the World: Market Share by Breath Actuated Inhalers Revenue in 2021
Figure 28. Global Breath Actuated Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Breath Actuated Inhalers Sales Market Share by Type (2017-2028)
Figure 30. Global Breath Actuated Inhalers Revenue Market Share by Type (2017-2028)
Figure 31. Global Breath Actuated Inhalers Sales Market Share by Application (2017-2028)
Figure 32. Global Breath Actuated Inhalers Revenue Market Share by Application (2017-2028)
Figure 33. North America Breath Actuated Inhalers Sales Market Share by Type (2017-2028)
Figure 34. North America Breath Actuated Inhalers Revenue Market Share by Type (2017-2028)
Figure 35. North America Breath Actuated Inhalers Sales Market Share by Application (2017-2028)
Figure 36. North America Breath Actuated Inhalers Revenue Market Share by Application (2017-2028)
Figure 37. North America Breath Actuated Inhalers Sales Share by Country (2017-2028)
Figure 38. North America Breath Actuated Inhalers Revenue Share by Country (2017-2028)
Figure 39. U.S. Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Breath Actuated Inhalers Sales Market Share by Type (2017-2028)
Figure 42. Europe Breath Actuated Inhalers Revenue Market Share by Type (2017-2028)
Figure 43. Europe Breath Actuated Inhalers Sales Market Share by Application (2017-2028)
Figure 44. Europe Breath Actuated Inhalers Revenue Market Share by Application (2017-2028)
Figure 45. Europe Breath Actuated Inhalers Sales Share by Country (2017-2028)
Figure 46. Europe Breath Actuated Inhalers Revenue Share by Country (2017-2028)
Figure 47. Germany Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 48. France Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Breath Actuated Inhalers Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Breath Actuated Inhalers Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Breath Actuated Inhalers Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Breath Actuated Inhalers Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Breath Actuated Inhalers Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Breath Actuated Inhalers Revenue Share by Region (2017-2028)
Figure 58. China Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 61. India Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Breath Actuated Inhalers Sales Market Share by Type (2017-2028)
Figure 69. Latin America Breath Actuated Inhalers Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Breath Actuated Inhalers Sales Market Share by Application (2017-2028)
Figure 71. Latin America Breath Actuated Inhalers Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Breath Actuated Inhalers Sales Share by Country (2017-2028)
Figure 73. Latin America Breath Actuated Inhalers Revenue Share by Country (2017-2028)
Figure 74. Mexico Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Breath Actuated Inhalers Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Breath Actuated Inhalers Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Breath Actuated Inhalers Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Breath Actuated Inhalers Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Breath Actuated Inhalers Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Breath Actuated Inhalers Revenue Share by Country (2017-2028)
Figure 83. Turkey Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Breath Actuated Inhalers Revenue (2017-2028) & (US$ Million)
Figure 86. Breath Actuated Inhalers Value Chain
Figure 87. Breath Actuated Inhalers Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---